Outcomes of Type 2 Diabetes Management: One Center Experience 2015–2023
<p id="p1">The purpose of this chapter was (1) to identify the frequency of employing different kinds of medication (beta-stimulators, metformin, gliflozins, incretins and/or insulins, pioglitazone, statins, fibrates), (2) to assess global metabolic effectiveness of this medication in a walk-in diab...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1155656 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Outcomes of Type 2 Diabetes Management: One Center Experience 2015–2023
- Pathophysiologic Approach to Type 2 Diabetes Management: One Centre Experience 1980–2020
- Intensive Management of Type 1 Diabetes in Adults: One Centre Experience 1970–2022
- Family-Centered Diabetes Care for Better Glycemic Outcomes of Outpatients in Rural Areas
- Individual and Group Education in Diabetes and Outcomes
- Nursing outcomes and social support intervention for diabetes self-management: consensus study
- Multi-Session Client-Centered Treatment Outcome Evaluation in Psychotherapy